ACRS vs VNQ
Aclaris Therapeutics Inc (ACRS) versus VNQ (VNQ) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
VNQ (VNQ) common stock.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
VNQ does not have a complete income-statement cache yet.
ACRS currently screens at market cap $615.9M. VNQ currently screens at market cap $0.
Not investment advice. Open the ACRS and VNQ stock pages for the full models.
Not investment advice.